BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8950952)

  • 1. [Thromboxane A2 receptor antagonist in asthma therapy].
    Endo S; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):3045-8. PubMed ID: 8950952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular pharmacology and application to the bronchial asthma of thromboxane A2 antagonists].
    Kohno S
    Nihon Rinsho; 1996 Feb; 54(2):551-8. PubMed ID: 8838113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thromboxane A2 synthase inhibitor and receptor antagonist].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial hyperresponsiveness to histamine induced by intravenous administration of thromboxane A2 (TXA2) in guinea-pigs].
    Tsukagoshi H; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1532-7. PubMed ID: 1808375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2 and related prostaglandins in airways.
    Devillier P; Bessard G
    Fundam Clin Pharmacol; 1997; 11(1):2-18. PubMed ID: 9182072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.
    Dogné JM; de Leval X; Benoit P; Delarge J; Masereel B
    Am J Respir Med; 2002; 1(1):11-7. PubMed ID: 14720071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma. Kanazawa Asthma Research Group.
    Fujimura M; Nakatsumi Y; Nishi K; Kasahara K; Matsuda T
    Pulm Pharmacol; 1995 Dec; 8(6):251-7. PubMed ID: 8819179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the selective thromboxane A2 receptor antagonist, S-1452, on antigen-induced sustained bronchial hyperresponsiveness.
    Arimura A; Asanuma F; Matsumoto Y; Kurosawa A; Jyoyama H; Nagai H
    Eur J Pharmacol; 1994 Aug; 260(2-3):201-9. PubMed ID: 7988644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids as pharmacological targets in COPD and asthma.
    Rolin S; Masereel B; Dogné JM
    Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pigs.
    Arimura A; Asanuma F; Kurosawa A; Harada M
    Int Arch Allergy Immunol; 1992; 98(3):239-46. PubMed ID: 1392626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice.
    Shi H; Yokoyama A; Kohno N; Hirasawa Y; Kondo K; Sakai K; Hiwada K
    Eur Respir J; 1998 Mar; 11(3):624-9. PubMed ID: 9596113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
    Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S
    Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bronchial hyperresponsiveness to histamine induced by intravenous administration of leukotriene C4 by novel thromboxane A2 receptor antagonists ONO-NT-126 and ONO-8809 in guinea-pigs.
    Kurosawa M; Yodonawa S; Tsukagoshi H
    Clin Exp Allergy; 1993 Oct; 23(10):843-50. PubMed ID: 10780891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of thromboxane A2 (TXA2) antagonists on bronchial hyperresponsiveness induced by intravenous administration of leukotriene C4 (LTC4) in guinea pigs].
    Yodonawa S; Tsukagoshi H; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):162-8. PubMed ID: 8515595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs].
    Tsukagoshi H; Kurosawa M
    Nihon Yakurigaku Zasshi; 1992 Feb; 99(2):83-91. PubMed ID: 1559641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aerosol administration of a thromboxane receptor antagonist (S-1452) on experimental asthma in guinea pigs.
    Saito M; Fujimura M; Mizuhashi K; Shintani H; Matsuda T
    Allergy; 1994 Sep; 49(8):680-4. PubMed ID: 7653751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].
    Itoh Y; Shindoh J; Horiba M; Kohno S; Ohata K; Ashida Y; Takagi K
    Arerugi; 1993 Nov; 42(11):1670-6. PubMed ID: 8279967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414.
    Kurokawa T; Matsumoto T; Ashida Y; Sasada R; Iwasa S
    Biol Pharm Bull; 1994 Mar; 17(3):383-5. PubMed ID: 8019502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.